IBEPZI Trademark

Trademark Overview

On Thursday, August 11, 2022, a trademark application was filed for IBEPZI with the United States Patent and Trademark Office. The USPTO has given the IBEPZI trademark a serial number of 97545044. The federal status of this trademark filing is REGISTERED as of Tuesday, April 23, 2024. This trademark is owned by Glaxo Group Limited. The IBEPZI trademark is filed in the Pharmaceutical Products category with the following description:

Prescription only medications for the treatment of viral infections
ibepzi

General Information

Serial Number97545044
Word MarkIBEPZI
Filing DateThursday, August 11, 2022
Status700 - REGISTERED
Status DateTuesday, April 23, 2024
Registration Number7363052
Registration DateTuesday, April 23, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements

Goods and ServicesPrescription only medications for the treatment of viral infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 17, 2022
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage, GB SG12NY
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage, GB SG12NY
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage, GB SG12NY

Trademark Events

Event DateEvent Description
Thursday, March 9, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, August 15, 2022NEW APPLICATION ENTERED
Wednesday, August 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 9, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 30, 2023ASSIGNED TO EXAMINER
Wednesday, June 7, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 7, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 3, 2023ASSIGNED TO LIE
Tuesday, December 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

ibepzi viral infections treatment medications only prescription